RECURRENT PROSTATE CANCER
Clinical trials for RECURRENT PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT PROSTATE CANCER trials appear
Sign up with your email to follow new studies for RECURRENT PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune-Boosting drug and vaccine aim to fight returning prostate cancer
Disease control Not yet recruitingThis Phase II trial tests whether an immune-boosting drug (N-803) alone or combined with a vaccine (ETBX-071) can lower PSA levels in men whose prostate cancer has returned after targeted radiation therapy. Participants receive up to eight cycles of treatment and are followed for…
Matched conditions: RECURRENT PROSTATE CANCER
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Tiny radioactive seeds aim to zap recurrent prostate cancer
Disease control Not yet recruitingThis early study tests a new device called Alpha DaRT, which places tiny radioactive seeds directly into prostate tumors that have returned after initial treatment. The main goal is to see if it's safe, with a secondary look at whether it can control the cancer. Up to 12 men with…
Matched conditions: RECURRENT PROSTATE CANCER
Phase: NA • Sponsor: Alpha Tau Medical LTD. • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Can a 2-week drug boost scan accuracy for hidden prostate cancer?
Knowledge-focused Not yet recruitingThis study looks at whether taking bicalutamide for two weeks can make PSMA PET/CT scans better at finding small amounts of prostate cancer that standard scans might miss. It involves 20 men with recurrent prostate cancer and very low PSA levels. Participants are randomly assigne…
Matched conditions: RECURRENT PROSTATE CANCER
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC